Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have earned an average recommendation of “Hold” from the five analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $7.45.
STEM has been the subject of a number of analyst reports. Roth Capital restated a “neutral” rating and issued a $6.75 price objective on shares of Stem in a research report on Monday, August 17th. Barclays decreased their target price on shares of Stem from $18.00 to $8.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Wall Street Zen upgraded shares of Stem from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 15th. Susquehanna cut their price target on shares of Stem from $10.00 to $7.50 and set a “neutral” rating for the company in a report on Friday, July 10th. Finally, UBS Group upgraded shares of Stem from a “neutral” rating to a “buy” rating and set a $7.00 price target for the company in a research report on Friday, September 25th.
Get Our Latest Stock Report on STEM
Institutional Investors Weigh In On Stem
Key Headlines Impacting Stem
Here are the key news stories impacting Stem this week:
- Neutral Sentiment: Education-related stories discuss youth ambassador applications, STEM grants, new school STEM centers, workforce initiatives and university programs. These may support long-term demand for technology talent but do not identify contracts, customers or funding for Stem, Inc. STEM Next Flight Crew opens applications for 2027 youth ambassadors MIT Launches National STEM Workforce Education Initiative Grades 6-12 STEM education project grants
- Neutral Sentiment: Research headlines cover embryonic stem cells, rejuvenated cells from an older donor, pediatric stem-cell work and a $100 million federal initiative for STEM researchers. The research funding could be broadly supportive of technology investment, but there is no disclosed connection to Stem’s storage platform. Trump announces $100 million for STEM researchers Blood cells from 80-year-old donor become stem cells
- Negative Sentiment: The headlines provide no new revenue catalyst or operational update for Stem, Inc. Against that backdrop, the company’s recent results showed revenue below expectations, a sizable per-share loss and forecasts for another loss this year, leaving investors focused on execution, liquidity and a potential turnaround rather than these unrelated STEM stories.
Stem Stock Performance
Shares of STEM opened at $4.16 on Friday. Stem has a 52-week low of $3.70 and a 52-week high of $32.23. The stock’s 50-day simple moving average is $5.14 and its 200 day simple moving average is $7.35. The stock has a market capitalization of $40.08 million, a price-to-earnings ratio of -0.49 and a beta of 1.58.
Stem (NYSE:STEM – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported ($1.58) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.75) by $0.17. The company had revenue of $33.65 million for the quarter, compared to analysts’ expectations of $36.65 million. On average, research analysts forecast that Stem will post -7.04 earnings per share for the current fiscal year.
About Stem
Stem, Inc is a clean-energy technology company that provides software and services for managing renewable energy and energy storage assets. Its platform is designed to help commercial, industrial and utility customers optimize electricity use, coordinate battery storage, and improve the performance of solar and other distributed energy resources.
The company’s offerings have included Athena, an artificial-intelligence-driven energy optimization platform, as well as software for monitoring, managing and reporting on renewable energy assets.
See Also
- Five stocks we like better than Stem
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
